Thursday, April 17, 2014 9:38:30 PM
supplement submitted to FDA 4/17/14 by Biel
http://www.regulations.gov/#!documentDetail;D=FDA-2012-N-0378-0050
Supplement from BioElectronics Corporation.
View all documents and comments in this Docket
This Other document was issued by the Food and Drug Administration (FDA)
For related information, Open Docket Folder Docket folder icon
Show agency attachment(s) AttachmentsView All (0) Empty
--------------------------------------------------------------
ContentView document:
See attached file(s)
No documents available.
AttachmentsView All (3) Empty
.Supplement from BioElectronics Corporation
View Attachment:
+ View more informationAuthors:
cdrh
..Attachment 1 Usability Study ActiPatch
View Attachment:
+ View more informationAuthors:
cdrh
..Attachment 2 Rawe Ian M The Case for Over the Counter Shortwave Therapy Safe and Effective Devices for Pain Management
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM